IL28B polymorphism involved in HCV-related carcinogenesis

被引:0
|
作者
机构
关键词
D O I
10.1038/nrgastro.2012.7
中图分类号
学科分类号
摘要
引用
收藏
页码:124 / 124
相关论文
共 50 条
  • [1] IL28B POLYMORPHISM AS PREDICTOR OF RESPONSE TO ANTI-HCV THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME
    Piluso, Alessia
    Giannini, Carlo
    Fognani, Elisa
    Gragnani, Laura
    Caini, Patrizio
    Monti, Monica
    Petrarca, Antonio
    Ranieri, Jessica
    Laffi, Giacomo
    Zignego, Anna Linda
    HEPATOLOGY, 2011, 54 : 841A - 841A
  • [2] HOST GENETIC VARIANTS AROUND IL28A/IL28B ASSOCIATED WITH HCV-RELATED OUTCOMES BASED ON REVEAL-HCV COHORT
    Shaw, G. T. W.
    Lee, M. -H.
    Yuan, Y.
    Yang, H. -I.
    Lin, Y. -J.
    Jen, C. -L.
    Lu, S. -N.
    Wang, L. -Y.
    You, S. -L.
    L'Italien, G.
    Chen, C. -J.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S202 - S202
  • [3] HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2
    De Re, Valli
    De Zorzi, Mariangela
    Caggiari, Laura
    Lauletta, Gianfranco
    Tornesello, Maria Lina
    Fognani, Elisa
    Miorin, Marta
    Racanelli, Vito
    Quartuccio, Luca
    Gragnani, Laura
    Russi, Sabino
    Pavone, Fabio
    Ghersetti, Michela
    Costa, Elena Garlatti
    Casarin, Pietro
    Bomben, Riccardo
    Mazzaro, Cesare
    Basaglia, Giancarlo
    Berretta, Massimiliano
    Vaccher, Emanuela
    Izzo, Francesco
    Buonaguro, Franco Maria
    De Vita, Salvatore
    Zignego, Anna Linda
    De Paoli, Paolo
    Dolcetti, Riccardo
    ONCOTARGET, 2016, 7 (25) : 37487 - 37497
  • [4] Value of IL28B genotyping in patients with HCV-related mixed cryoglobulinemia: results of a large, prospective study
    Piluso, A.
    Giannini, C.
    Fognani, E.
    Gragnani, L.
    Caini, P.
    Monti, M.
    Petrarca, A.
    Ranieri, J.
    Urraro, T.
    Triboli, E.
    Laffi, G.
    Zignego, A. L.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 (04) : e107 - e114
  • [5] ETIOLOGICAL THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME: THE ROLE OF IL28B GENOTYPE AS PREDICTOR OF RESPONSE
    Urraro, T.
    Piluso, A.
    Giannini, C.
    Fognani, E.
    Gragnani, L.
    Caini, P.
    Monti, M.
    Triboli, E.
    Pellegrini, E.
    Petrarca, A.
    Ranieri, J.
    Laffi, G.
    Zignego, A. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 117 - 118
  • [6] IL28B gene polymorphism; A predictor for HCV clearance with standard therapy
    Prasad, S. S.
    Rao, P. N.
    Gupta, R.
    Tandan, M.
    Mukherjee, R. M.
    Atmakuri, M.
    Reddy, D. N.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 158 - 158
  • [7] Impact of Immunogenetic IL28B Polymorphism on Natural Outcome of HCV Infection
    De Re, Valli
    Gragnani, Laura
    Fognani, Elisa
    Piluso, Alessia
    Izzo, Francesco
    Mangia, Alessandra
    Crovatto, Marina
    Gava, Graziella
    Casarin, Pietro
    Sansonno, Domenico
    Racanelli, Vito
    De Vita, Salvatore
    Pioltelli, Pietro
    Caggiari, Laura
    De Zorzi, Mariangela
    Berretta, Massimiliano
    Gini, Andrea
    Zucchetto, Antonella
    Buonaguro, Franco Maria
    De Paoli, Paolo
    Zignego, Anna Linda
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [8] Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism
    Zoller, Heinz
    Jenal, Annina
    Staettermayer, Albert F.
    Schroecksnadel, Sebastian
    Ferenci, Peter
    Fuchs, Dietmar
    PHARMACEUTICALS, 2015, 8 (02): : 337 - 350
  • [9] IL28B genotype on HCV infection in Asia
    Liu C.-H.
    Kao J.-H.
    Current Hepatitis Reports, 2013, 12 (3) : 149 - 156
  • [10] IMPACT OF IL28B POLYMORPHISM ON TREATMENT DURATION IN HCV GENOTYPE 1 AND 4 PATIENTS
    Scherzer, Thomas-Matthias
    Staettermayer, Albert
    Kessler, Harald H.
    Gschwantler, Michael
    Strasser, Michael P.
    Laferl, Hermann
    Maieron, Andreas
    Stauber, Rudolf E.
    Datz, Christian
    Rutter, Karoline
    Beinhardt, Sandra
    Steindl-Munda, Petra E.
    Hofer, Harald
    Ferenci, Peter
    HEPATOLOGY, 2010, 52 (04) : 765A - 765A